Kit ELISA TRANCE sandwich (RANKL/TNFSF11) (mouse): quantitative assay of Ms TRANCE in serum, plasma or cell culture medium. The test exclusively recognizes the natural and recombinant forms of Ms TRANCE.
Kit ELISA TRANCE sandwich (RANKL/TNFSF11) (mouse): quantitative assay of Ms TRANCE in serum, plasma or cell culture medium. The test exclusively recognizes the natural and recombinant forms of Ms TRANCE.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
RANKL (Receptor Activator of Nuclear Factor kappa-B Ligand,Trance, TNFSK11) is a member of the tumour necrosis factor (TNF) cytokine family, which is a ligand for osteoprotein and plays a key role in the differentiation and activation of osteoclasts. Structurally, RANKL shares the structural support of TNF family members, but has individual receptor-ligand pairs that associate with high specificity. It has been shown that RANKL self-associates as a homotrimer with four surface loops distinct from other TNF molecules. RANKL has been shown to be a survival factor for dendritic cells and is involved in regulating T-cell-dependent immune response. T cell activation has been reported to induce RANKL expression and lead to increased osteoclastogenesis and bone loss. RANKL has been shown to activate AKT/PKB antiapoptotic kinase via a signaling complex involving SRC kinase and the receptor-associated factor of tumour necrosis factor (TRAF) 6, indicating that RANKL could play a role in the regulation of cell apoptosis. Targeted disturbance of a RANKL gene in mice resulted in severe osteopretrose and lack of osteoclasts. Deficiencies in the early differentiation of T and B lymphocytes were observed in mice and were not able to form lobulo-alveolar breast structures during pregnancy. Two alternative spliced transcription variants were found for RANKL.
Sensitivity
Sensitivity of the dosage: 4 pg/ml.
Measurement range
Dose range: 2.74-2000 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Reproducibility
Intradose variation coefficient < 10%, interdose < 12%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15475343 |
| Specifications |
| Accession number | O35235 |
| Dose range | 2.74-2000 pg/ml |
| Sensitivity of the dosage | 4 pg/ml |
| Calibration range | 4 pg/ml to 2000 pg/ml |
| Dose | ELISA solid-phase sandwich |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Protein family | Cytokines & receptors |
| Type of sample | Serum, Surnatant, Surnatant |
| Specificity | This ELISA kit shows no cross-reactivity with the following tested cytokines: mouse CD30, L CD30, T CD40, CRG-2, CTACK, CXCL16, eotaxin, eotaxin-2, Ligand Fas, fractalkine, GCSF, GM-CFS, IFN-gamma, IGFBP-3, IGFBP-5, IGFBP-6, IL-1 alpha, IL-1 beta, IL-2, IL-3, IL-3 Rb, IL-4, IL-5, IL-5, IL- |
| Sufficient for | 96 dosages |
| Target species | Mouse |
| For use with (application) | ELISA, protein dosage, protein biology, cancerology, immunology, neuroscience, neurobiology, protein detection, protein analyses |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 21943 |
| Gene symbol(s) | Ly109l,ODF,OPGL,RANKL,Trance |
| Coefficient of inter-dose variation | < 12 % |
| Coefficient of intra-dose variation | < 10 % |
| Contents of kits | 96-well pre-coated plate, Standard, Dose diluent concentrate, Biotinylated detection antibody, Wash pad, Chromogen, Stop solution, Adhesive plate covers, Adhesive plate covers |
| Marker or dye | HRP |
| Quantity | 96 tests |
| Regulatory status | RUO |
| Research disciplines | Bone research |
| Synonym | Ly109l, ODF, OPG, OPGL, RANKL, Trance. dia.ext. |
| Target | Mouse |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 33 μl; Serum, 33 μl; Supernatant, 100 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | EMTNFSF11 |
|---|
| Country of origin | United States |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.